Cor van der Leest

1.5k total citations · 1 hit paper
28 papers, 981 citations indexed

About

Cor van der Leest is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Cor van der Leest has authored 28 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Cor van der Leest's work include Lung Cancer Treatments and Mutations (15 papers), Colorectal Cancer Treatments and Studies (9 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Cor van der Leest is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Colorectal Cancer Treatments and Studies (9 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Cor van der Leest collaborates with scholars based in Netherlands, Italy and United States. Cor van der Leest's co-authors include Joachim G.J.V. Aerts, Henk C. Hoogsteden, Bianca den Hamer, Peter Riegman, Jun Hou, Michael den Bakker, Sjaak Philipsen, Frank Grosveld, Peter J. van der Spek and John A. Foekens and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Cor van der Leest

27 papers receiving 968 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction

2010 614 citations Jun Hou, Joachim G.J.V. Aerts et al. PLoS ONE profile →

Peers

Countries citing papers authored by Cor van der Leest

Since Specialization

Citations

This map shows the geographic impact of Cor van der Leest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cor van der Leest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cor van der Leest more than expected).

Fields of papers citing papers by Cor van der Leest

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cor van der Leest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cor van der Leest. The network helps show where Cor van der Leest may publish in the future.

Co-authorship network of co-authors of Cor van der Leest

This figure shows the co-authorship network connecting the top 25 collaborators of Cor van der Leest. A scholar is included among the top collaborators of Cor van der Leest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cor van der Leest. Cor van der Leest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circulating Tumor DNA in Advanced EGFRex20+ NSCLC: Concordance with Tissue Biopsy, Monitoring of Response, and Resistance to High-Dose Osimertinib 2025 ·Targeted Oncology ·(unknown), (unknown), (unknown), Adrianus J. de Langen, Lizza Hendriks, Michel M. van den Heuvel, Cor van der Leest, Sayed M.S. Hashemi, Paul van der Leest, T. Jeroen N. Hiltermann, Ed Schuuring, Anthonie J. van der Wekken	1
2	Exploring the impact of patient‐specific clinical features on osimertinib effectiveness in a real‐world cohort of patients with EGFR mutated non‐small cell lung cancer 2023 ·International Journal of Cancer ·(unknown), G. Veerman, (unknown), (unknown), (unknown), (unknown), (unknown), Marthe S. Paats, Vivianne C. G. Tjan‐Heijnen, Cor van der Leest, Anne‐Marie C. Dingemans, Ron H.J. Mathijssen, E.M.W. van de Garde, Patrick C. Souverein, Johanna H. M. Driessen, Lizza Hendriks, Robin M.J.M. van Geel, Sander Croes	7
3	Incidence of Bone Metastases and Skeletal-Related Events in Patients With EGFR-Mutated NSCLC Treated With Osimertinib 2023 ·JTO Clinical and Research Reports ·(unknown), (unknown), G. Veerman, (unknown), (unknown), Cor van der Leest, Sander Croes, Anne‐Marie C. Dingemans, Lizza Hendriks	5
4	High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: Results from the phase 2 multicenter POSITION20 trial 2022 ·Lung Cancer ·(unknown), (unknown), Lizza Hendriks, T. Jeroen N. Hiltermann, Birgitta I. Hiddinga, (unknown), Arja ter Elst, Sayed M.S. Hashemi, Anne‐Marie C. Dingemans, Cor van der Leest, Adrianus J. de Langen, Michel M. van den Heuvel, Anthonie J. van der Wekken	38
5	The development of the ADO-SQ model to predict 1-year mortality in patients with COPD 2022 ·Palliative Medicine ·(unknown), Cor van der Leest, G.B. Helfrich, Roxane Heller-Baan, (unknown), (unknown), Daan Nieboer, (unknown), Agnes van der Heide	5
6	Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer 2021 ·Thorax ·Sabine Visser, Stijn L.W. Koolen, (unknown), Nico van Walree, Cor van der Leest, Robin Cornelissen, Ron van Schaik, Ron H.J. Mathijssen, Joachim G.J.V. Aerts, Bruno H. Stricker	6
7	Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer 2020 ·Cancers ·(unknown), G. Veerman, (unknown), Peggy N. Atmodimedjo, Marthe S. Paats, Cor van der Leest, Jan H. von der Thüsen, (unknown), Esther Oomen‐de Hoop, Stijn L.W. Koolen, Winand N.M. Dinjens, Ron H. N. van Schaik, Ron H.J. Mathijssen, Joachim G.J.V. Aerts, Hendrikus J. Dubbink, Anne‐Marie C. Dingemans	16
8	Preoperative mediastinal staging in patients with cT1‐3NxM0 non‐small cell lung cancer 2020 ·Thoracic Cancer ·(unknown), (unknown), Hans G.W. de Groot, Ninos Ayez, Cor van der Leest, Joachim G.J.V. Aerts, Eelco J. Veen	1
9	Plasma Cell-Free DNA Testing of Patients With EGFR Mutant Non–Small-Cell Lung Cancer: Droplet Digital PCR Versus Next-Generation Sequencing Compared With Tissue-Based Results 2019 ·JCO Precision Oncology ·(unknown), Peggy N. Atmodimedjo, Evert de Jonge, Marthe S. Paats, Cor van der Leest, Esther Oomen‐de Hoop, Maurice P.H.M. Jansen, Marzia Del Re, Jan H. von der Thüsen, Winand N.M. Dinjens, (unknown), Joachim G.J.V. Aerts, Hendrikus J. Dubbink	15
10	OA13.06 Autologous Dendritic Cells Loaded with Allogeneic Tumor Cell Lysate (Pheralys®) in Patients with Mesothelioma: Final Results of a Phase I Study 2017 ·Journal of Thoracic Oncology ·Joachim G.J.V. Aerts, Robin Cornelissen, Cor van der Leest, Joost P. Hegmans, Koen Bezemer, Margaretha E.H. Kaijen-Lambers, Ferry A.L.M. Eskens, Eric Braakman, Bronno van der Holt, Rudi W. Hendriks, Henk C. Hoogsteden	5
11	Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples – a short report 2017 ·Cellular Oncology ·Nick Beije, Jaco Kraan, Michael A. den Bakker, Alexander P.W.M. Maat, Cor van der Leest, Robin Cornelissen, (unknown), John W.M. Martens, Joachim G.J.V. Aerts, Stefan Sleijfer	5
12	Association of single nucleotide polymorphisms with efficacy in nivolumab-treated NSCLC patients 2017 ·Annals of Oncology ·Edwin A. Basak, Sander Bins, Samira El Bouazzaoui, Stijn L.W. Koolen, Esther Oomen‐de Hoop, Cor van der Leest, Astrid A.M. van der Veldt, Stefan Sleijfer, Reno Debets, Ron H. N. van Schaik, Ron H.J. Mathijssen, Joachim G.J.V. Aerts	1
13	Association between single nucleotide polymorphisms and side effects in nivolumab treated NSCLC patients 2016 ·Annals of Oncology ·Sander Bins, Edwin A. Basak, Samira El Bouazzaoui, Stijn L.W. Koolen, Cor van der Leest, Stefan Sleijfer, Reno Debets, Ron H. N. van Schaik, Joachim G.J.V. Aerts, Ron H.J. Mathijssen	1
14	Emergency diagnosis of lung cancer: An international problem. 2015 ·Journal of Clinical Oncology ·Thomas Newsom-Davis, Rossana Berardi, (unknown), Linda Coate, Ana Figueiredo, Gabriele Gamerith, (unknown), Marko Jakopović, Cor van der Leest, Damien Pouessel, Marcello Tiseo, (unknown), (unknown)	4
15	SUVmax during 18FDG-PET scanning in small cell lung cancer: Similar information as in non-small cell lung cancer? 2011 ·Lung Cancer ·Cor van der Leest, Egbert F. Smit, Jara M. Baas, (unknown), Nico van Walree, Henk C. Hoogsteden, Joachim G.J.V. Aerts	19
16	Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction breakdown → 2010 ·PLoS ONE ·Jun Hou, Joachim G.J.V. Aerts, Bianca den Hamer, Wilfred F. J. van IJcken, Michael den Bakker, Peter Riegman, Cor van der Leest, Peter J. van der Spek, John A. Foekens, Henk C. Hoogsteden, Frank Grosveld, Sjaak Philipsen	614
17	Characterization of Mediastinal Lymph Node Physiology In Vivo by Optical Spectroscopy during Endoscopic Ultrasound-Guided Fine Needle Aspiration 2010 ·Journal of Thoracic Oncology ·Stephen C. Kanick, Cor van der Leest, Remco S. Djamin, (unknown), Henk C. Hoogsteden, Henricus J. C. M. Sterenborg, Arjen Amelink, Joachim G.J.V. Aerts	30
18	Incorporation of Single Fiber Reflectance Spectroscopy into Ultrasound-Guided Endoscopy (EUS-FNA) of Mediastinal Lymph Nodes 2010 ·Stephen C. Kanick, Cor van der Leest, Joachim G.J.V. Aerts, Henricus J. C. M. Sterenborg, Arjen Amelink	0
19	Integration of single-fiber reflectance spectroscopy into ultrasound-guided endoscopic lung cancer staging of mediastinal lymph nodes 2010 ·Journal of Biomedical Optics ·Stephen C. Kanick, Cor van der Leest, Joachim G.J.V. Aerts, Henk C. Hoogsteden, Slávka Kaščáková, Henricus J. C. M. Sterenborg, Arjen Amelink	47
20	HIF1a expression in bronchial biopsies correlates with tumor microvascular saturation determined using optical spectroscopy 2007 ·Lung Cancer ·Joachim G.J.V. Aerts, Arjen Amelink, Cor van der Leest, Joost P. Hegmans, Annabrita Hemmes, Bianca den Hamer, Henricus J. C. M. Sterenborg, Henk C. Hoogsteden, Bart N. Lambrecht	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact